导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 97.86% | 2/1050 |
| 近一周 | -0.25% | 46/1104 |
| 近一月 | -6.08% | 734/1102 |
| 近一季 | 3.61% | 141/1092 |
| 近半年 | 66.02% | 7/1070 |
| 近一年 | 98.13% | 10/1018 |
| 近两年 | 196.06% | 58/926 |
| 近三年 | 114.24% | 74/834 |
| 成立以来 | 55.25% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
17.59% 13/1070 |
123.28% 8/1101 |
- - |
- - |
| 2025 | 22.47% 625/1065 |
-0.33% 814/1014 |
-5.40% 964/1038 |
38.83% 211/1050 |
-6.45% 767/1065 |
| 2024 | -8.56% 753/1011 |
-7.91% 694/960 |
-5.07% 640/983 |
7.49% 800/991 |
-2.70% 511/1011 |
| 2023 | 3.56% 52/952 |
13.49% 64/880 |
11.66% 15/895 |
-14.50% 761/915 |
-4.41% 443/952 |
| 2022 | -37.75% 721/867 |
-20.64% 553/773 |
10.58% 242/806 |
-15.05% 569/845 |
-16.50% 837/867 |
| 2021 | 32.04% 60/740 |
-11.88% 523/580 |
25.87% 77/659 |
11.95% 46/704 |
6.34% 168/740 |
| 2020 | 21.95% 378/554 |
-2.67% 229/419 |
14.99% 354/466 |
-3.06% 446/517 |
12.40% 274/554 |
| 2019 | 24.12% 317/410 |
26.60% 579/1146 |
-7.63% 894/1228 |
0.78% 315/390 |
5.33% 337/410 |
| 2018 | - - |
- - |
- - |
-3.96% 415/1000 |
-6.05% 83/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 汇安趋势动力股票C VS. 东吴新产业精选股票A(580008) |